InvestorsHub Logo
Followers 17
Posts 1806
Boards Moderated 0
Alias Born 03/29/2011

Re: J0hn Dope post# 64032

Monday, 12/11/2017 12:09:29 AM

Monday, December 11, 2017 12:09:29 AM

Post# of 140464
I can't disagree that listing on a major exchange is a benefit but that would be a ways off for this company. In the mean time, they still has to raise a chunk of change for continuing R&D efforts, the state they are currently in. Maybe after FDA approval and entering production stage (and meeting other major stock exchange guidlines/rules), then maybe listing on a major exchange is possible. But my point would be this company is still far from that being still only in R&D stage.

So in Jan or Feb they will need to raise more money for continuing R&D (or else close up shop). Thinking that means another offering or round
of warrants? And frankly there will be many more fundraising rounds to come. Anyway, I don't think current share prices are particularly attractive for raising funds that way (I'm not sure they could get the borrowing with no income in site), so I'm thinking the R/S (1/10?) will occur just before the next offering to make it worthwhile for fundraising.

Of course there are many causal effects of R/S but I'm more concerned of wthe when ... and I welcome further discussions....